HCmed Signs a Global Development Agreement with Global Biotechnology Leader CSL Behring

Companies Initiated Phase I trial in December 2020 TAIPEI, May 4, 2021 /PRNewswire/ -- HCmed today announces the start of a strategic partnership with global biotherapeutics leader CSL Behring t...

Full "IntellAsia: Resources" article